A novel mechanism for the regulation of amyloid precursor protein metabolism

Journal of Cell Biology

Volumn 158, Issue 1, 2002, Pages 79-89

  Chen, Qi ^a   Kimura, Hideo ^b   Schubert, David ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Amyloid precursor protein; Beta amyloid; MOCA; Proteasome; Secretion

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MEMBRANE PROTEIN; PRESENILIN 1; PRESENILIN 2; PROTEASOME INHIBITOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CATABOLISM; CELL ADHESION; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BACTERIAL PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL ADHESION; CELL LINE; CYSTEINE ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; LAMININ; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MULTIENZYME COMPLEXES; NEURONS; PHENOTYPE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037043330     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200110151     Document Type: Article

References (66)

1. Regulation of amyloid precursor protein (APP)-binding to collagen and mapping of the binding sites on APP and collagen type I
2. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservation of Notch1 signaling
3. 1-42/1-40 ratio in vitro and in vivo
4. Gamma-secretase cleavage is distinct from endoplasmic reticulum degradation of the transmembrane domain of the amyloid precursor protein
5. Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch
6. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein
7. Role of the proteasome in Alzheimer's disease
8. An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types
9. Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation
10. Heat shock alters Alzheimer's β-amyloid precursor protein expression in human endothelial cells
11. (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
12. Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata
13. Lacracystin and clasto-lacracystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation
14. Proteolytic processing and cell biological functions of the amyloid precursor protein
15. A presenilin-1-dependent γ-secrerase-like protease mediates release of Notch intracellular domain
16. Protein topology of presenilin 1
17. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin 1
18. Presenilin I expression in yeast lowers secretion of the amyloid precursor protein
19. Lactacystin, proteasome function, and cell fate
20. 1-42, respectively
21. Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway
22. Alternative splicing generates a secreted form of N-CAM in muscle and brain
23. Lin-12/Notch signaling lessons from worms and flies
24. Amyloid β-peptide is produced by cultured cells during normal metabolism
25. Protease inhibitors divert amyloid precursor protein to the secretory pathway
26. Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism
27. Protein oligomerization in the endoplasmic reticulum
28. Peptides containing RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension
29. Isolation and characterization of a novel presenilin binding protein
30. Presenilin-1 mutations down-regulate the signalling pathway of the unfolded protein response
31. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies
32. Protein degradation in the endoplasmic reticulum
33. Proteasome inhibitors induce the association of Alzheimer's amyloid precursor with Hsc73
34. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions
35. Expoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
36. Regulation of amyloid precursor protein cleavage
37. Effects of PS1 deficiency on membrane protein trafficking in neurons
38. A role for presenilin-1 in nuclear accumulation of IRE1 fragments and induction of the mammalian unfolded protein response
39. Alzheimer's amyloid precursor protein α-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: Similarities to the angiotensin converting enzyme secretase
40. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome I related to the Alzheimer's disease type 3 gene
41. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
42. The expression of amyloid beta protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix
43. Clonal cell lines from the rat central nervous system
44. The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion
45. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
46. Expression of amyloid precursor protein in human astrocytes in vitro: Isoform-specific increases following heat shock
47. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
48. In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal
49. Cellular mechanisms of β-amyloid production and secretion
50. An accomplice for γ-secretase brought into focus
51. 1-42 peptides within secretory and endocytic compartments
52. Presenilin is required for activity and nuclear access of Notch in Drosophila
53. Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum
54. N-CAM and N-cadherin expression during in vitro chondrogenesis
55. Binding partners of Alzheimer's disease proteins: Are they physiologically relevant?
56. The role of presenilins in γ-secretase activity
57. A substrate-based difluoroketone selectively inhibits Alzheimer's γ-secretase activity
58. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving asparty protease
59. Appican expression induces morphological changes in C6 glioma cells and promotes adhesion of neural cells to the extracellular matrix
60. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation
61. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation
62. Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis
63. 40-42 secretion
64. Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants
65. Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notchl transmembrane domains
66. Calpain inhibitor I increases β-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase: Evidence that substrate availability limits β-amyloid peptide production